Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BrightSpring Health Services (BTSG) EBITDA Margin (2023 - 2025)

BrightSpring Health Services (BTSG) has disclosed EBITDA Margin for 3 consecutive years, with 3.04% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin fell 524.0% year-over-year to 3.04%, compared with a TTM value of 2.29% through Dec 2025, down 26.0%, and an annual FY2025 reading of 2.29%, up 24.0% over the prior year.
  • EBITDA Margin was 3.04% for Q4 2025 at BrightSpring Health Services, up from 2.63% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 8.28% in Q4 2024 and bottomed at 9.99% in Q4 2023.
  • Average EBITDA Margin over 3 years is 1.19%, with a median of 1.97% recorded in 2025.
  • The sharpest move saw EBITDA Margin surged 1827bps in 2024, then crashed -524bps in 2025.
  • Year by year, EBITDA Margin stood at 9.99% in 2023, then skyrocketed by 183bps to 8.28% in 2024, then plummeted by -63bps to 3.04% in 2025.
  • Business Quant data shows EBITDA Margin for BTSG at 3.04% in Q4 2025, 2.63% in Q3 2025, and 1.54% in Q2 2025.